Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine in Severe COVID-19
NCT04820751Phase 3Unknown
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cyproheptadine in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
cyproheptadine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04820751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04820751.